Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹3,393 Cr₹2,645 Cr₹3,812 Cr₹2,903 Cr₹2,560 Cr

What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?

The latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA is ₹3,393 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹3,393 Cr
Mar2024₹2,645 Cr
Mar2023₹3,812 Cr
Mar2022₹2,903 Cr
Mar2021₹2,560 Cr

How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹3,393 Cr
28.29
Mar2024 ₹2,645 Cr
-30.62
Mar2023 ₹3,812 Cr
31.33
Mar2022 ₹2,903 Cr
13.37
Mar2021 ₹2,560 Cr -

Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,207.4 Cr -1.5% 7.1% -19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,136.0 Cr -1.3% 0.9% -8.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.5%

7.1%

-19.7%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses